Literature DB >> 10449301

Abacavir rechallenge has to be avoided in case of hypersensitivity reaction.

L Escaut, J Y Liotier, E Albengres, N Cheminot, D Vittecoq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10449301     DOI： 10.1097/00002030-199907300-00026

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  16 in total

Review 1.  Pharmacogenetics as a tool to tailor antiretroviral therapy: A review.

Authors:  Antonio Aceti; Laura Gianserra; Lara Lambiase; Alfredo Pennica; Elisabetta Teti
Journal:  World J Virol       Date:  2015-08-12

Review 2.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

3.  Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo.

Authors:  Hauke Walter; Barbara Schmidt; Marianne Werwein; Eva Schwingel; Klaus Korn
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 4.  Drug Hypersensitivity.

Authors:  Ruwen Böhm; Ehrhardt Proksch; Thomas Schwarz; Ingolf Cascorbi
Journal:  Dtsch Arztebl Int       Date:  2018-07-23       Impact factor: 5.594

Review 5.  Hypersensitivity reactions to HIV therapy.

Authors:  Mas Chaponda; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 6.  Abacavir: a review of its clinical potential in patients with HIV infection.

Authors:  P S Hervey; C M Perry
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

7.  PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Authors:  Julia M Barbarino; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2015-04       Impact factor: 2.089

8.  Abacavir-induced fulminant hepatic failure in a HIV/HCV co-infected patient.

Authors:  Christopher Haas; Mary Rodriguez Ziccardi; Jody Borgman
Journal:  BMJ Case Rep       Date:  2015-12-15

9.  Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.

Authors:  Annalise M Martin; David Nolan; Silvana Gaudieri; Coral Ann Almeida; Richard Nolan; Ian James; Filipa Carvalho; Elizabeth Phillips; Frank T Christiansen; Anthony W Purcell; James McCluskey; Simon Mallal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

10.  PharmGKB summary: abacavir pathway.

Authors:  Julia M Barbarino; Deanna L Kroetz; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-05       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.